O'Shaughnessy Asset Management’s Evofem Biosciences, Inc. Common Stock EVFM Stock Holding History

O'Shaughnessy Asset Management’s Portfolio EVFM Stock Details EVFM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-12	Closed	–	–	2769
2021 Q3	$0	Hold	12	–	–	﹤0.01%	2916
2021 Q2	$0	Hold	12	–	–	﹤0.01%	2743
2021 Q1	$0	Hold	12	–	–	﹤0.01%	2511
2020 Q4	$0	Hold	12	–	–	﹤0.01%	2286
2020 Q3	$0	Hold	12	–	–	﹤0.01%	2062
2020 Q2	$1K	Buy	+12	New	+$809	﹤0.01%	1691

Other funds holding EVFM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

FWSM

First Wilshire Securities Management Pasadena, California $444M AUM 42.88% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

O'Shaughnessy Asset Management's EVFM Position: Q4 2021 in Review

O'Shaughnessy Asset Management sold out of Evofem Biosciences, Inc. Common Stock (EVFM) in Q4 2021, closing a stake of 12 shares.

O'Shaughnessy Asset Management first reported a position in EVFM in Q2 2020 and held it in 6 quarters. The position peaked at $1K in Q2 2020. 62 funds tracked by Wall St. Rank hold EVFM as of Q4 2021.

O'Shaughnessy Asset Management reported no remaining Evofem Biosciences, Inc. Common Stock position as of Q4 2021 after selling out during the quarter.
O'Shaughnessy Asset Management sold 12 Evofem Biosciences, Inc. Common Stock shares in Q4 2021.
O'Shaughnessy Asset Management first reported a position in Evofem Biosciences, Inc. Common Stock in Q2 2020 and held it in 6 quarters.
O'Shaughnessy Asset Management's Evofem Biosciences, Inc. Common Stock position peaked at $1K in Q2 2020.
62 funds tracked by Wall St. Rank held Evofem Biosciences, Inc. Common Stock as of Q4 2021.

Based on O'Shaughnessy Asset Management's 13F filing for Q4 2021, filed 11 Feb 2022.